Found: 7
Select item for more details and to access through your institution.
Comparison of ex vivo stability of copeptin and vasopressin.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2017, v. 55, n. 7, p. 948, doi. 10.1515/cclm-2016-0559
- By:
- Publication type:
- Article
Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
- Published in:
- Nephrology Dialysis Transplantation, 2017, v. 32, p. i146, doi. 10.1093/ndt/gfw391
- By:
- Publication type:
- Article
Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease.
- Published in:
- Nephrology Dialysis Transplantation, 2012, v. 27, n. 11, p. 4131, doi. 10.1093/ndt/gfs070
- By:
- Publication type:
- Article
Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0169263
- By:
- Publication type:
- Article
Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis?
- Published in:
- American Journal of Nephrology, 2015, v. 41, n. 3, p. 248, doi. 10.1159/000382081
- By:
- Publication type:
- Article
Dialysis Hypotension: A Role for Inadequate Increase in Arginine Vasopressin Levels? A Systematic Literature Review and Meta-Analysis.
- Published in:
- American Journal of Nephrology, 2014, v. 39, n. 2, p. 100, doi. 10.1159/000358203
- By:
- Publication type:
- Article